Mondaq Canada: Food, Drugs, Healthcare, Life Sciences
Miller Thomson LLP
For the first time in a while, there are some sweeping new labelling disclosure requirements coming into play for the food industry, at both the Ontario and federal levels.
McMillan LLP
Privacy matters to Ontarians and even more so, in light of a number of highly publicized breaches of sensitive personal health information in circumstances where one would expect PHI to be protected...
Norton Rose Fulbright Canada LLP
In the liability phase, the Federal Court (FC) found that Canadian Patent No. 1,161,380 (380 Patent) was valid and infringed by Apotex.
Norton Rose Fulbright Canada LLP
The Minister of Health refused to list a patent on the Patent Register in respect of a fixed-dose combination product because it did not contain a claim for each medicinal ingredient in the approved product.
Miller Thomson LLP
Organizations engaged in research involving humans are required to have proposed projects reviewed by a research ethics board ("REB").
Norton Rose Fulbright Canada LLP
AstraZeneca Canada Inc. (AstraZeneca) appealed from the decision of Justice Rennie of the Federal Court (reported as AstraZeneca Canada Inc. v. Apotex Inc., 2014 FC 638) holding that AstraZeneca's ‘653 Patent was invalid for lack of demonstrated or soundly predicted utility.
McCarthy Tétrault LLP
In Charlton v. Abbott Laboratories, Ltd., 2015 BCCA 26, the Court of Appeal for British Columbia overturned certification of a class action on behalf of all Canadian consumers of sibutramine, a weight-loss drug.
Norton Rose Fulbright Canada LLP
Horizon Pharma PLC is seeking approval to market the drug RAVICTI (glycerol phenylbutyrate) for the treatment of urea cycle disorders.
Norton Rose Fulbright Canada LLP
Apotex Inc. (Apotex) and Apotex Pharmachem Inc. (Pharmachem) have been ordered by the Federal Court to pay to Adir and Servier Canada Inc. (collectively Servier) within 60 days a combined total of Canadian $61 million plus interest.
Field LLP
Dr. Farhat, an internationally trained pediatric radiologist, was recruited to work in Calgary. He was registered on the College's courtesy register during a fellowship.
DLA Piper
The federal Food and Drugs Act (the "FDA") establishes the main regulatory framework and provides the basic criteria for the lawful advertising of drugs in Canada.
Gowling Lafleur Henderson LLP
Justice O'Reilly of the Federal Court has rejected Teva's allegations of invalidity regarding Novartis's patent covering its iron chelator product EXJADE (deferasirox).
TTL Health Law
In 1968, the Phillip Morris Company introduced Virginia Slims, a brand of cigarette's marketed to young, professional women.
Gowling Lafleur Henderson LLP
The Regulations published are in substantially the same form as previously presented in the Notice of May 3, 2015.
Norton Rose Fulbright Canada LLP
The Federal Court issued a Notice to the Parties and the Profession dated June 24, 2015 (the "Notice") containing its initial recommendations for achieving increased proportionality in proceedings before the Court.
Norton Rose Fulbright Canada LLP
A new definition of "claim for the formulation" has been introduced.
MNP
Spring always tends to bring a renewed sense of optimism, and for the BC Wine Industry, there seems to be good reason for cautious optimism for what lies ahead during the remainder of 2015.
Norton Rose Fulbright Canada LLP
Previously announced amendments to the Patented Medicines (Notice of Compliance) Regulations (PM(NOC) Regulations) were registered and brought into force on June 19, 2015 (the Amendments).
Fuller Landau
Read the Spring/Summer 2015 edition of our Food & Beverage Newsletter.
Blake, Cassels & Graydon LLP
On June 13, 2015, the Government of Canada published proposed amendments to the Food and Drug Regulations that, if adopted, would significantly change key elements of the nutrition labelling of food products.
Latest Video
Most Popular Recent Articles
McMillan LLP
Privacy matters to Ontarians and even more so, in light of a number of highly publicized breaches of sensitive personal health information in circumstances where one would expect PHI to be protected...
McCarthy Tétrault LLP
On appeal, the key dispute was whether a non-infringing alternative is a relevant factor to be considered in assessing patent infringement damages.
McCarthy Tétrault LLP
Earlier this year, the Ontario Court of Appeal released its decision in Hopkins v. Kay, 2015 ONCA 112, in which it held that the mere existence of a legislative scheme to address privacy-related breaches of personal health information does not preclude a private action from being brought to address said breaches.
McCarthy Tétrault LLP
On January 7, 2015, Justice de Montigny of the Federal Court released his judgment and reasons in Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC, 2015 FC 17.
Clark Wilson LLP
Here is one statistic you can rely on: 100% of Canadians will die. Benjamin Franklin said it first, "In this world nothing can be said to be certain, except death and taxes."
CCPartners
In Ontario more than 550,000 people work at hospitals, long-term care homes and other health care workplaces.
Goudreau Gage Dubuc
Last December, the Federal Court of Canada overturned a decision of the Commissioner of Patents to refuse a patent claiming a fixed dosage regimen for the drug Humira® (Adalimunab) used in rheumatoid arthritis.
Torys LLP
Manufacturers and distributors intending to market their U.S. dietary supplements in Canada will want to understand the regulation of dietary supplements in the U.S.
Norton Rose Fulbright Canada LLP
The global pharmaceutical sector has been rocked by several significant mergers and acquisitions in 2015...
Affleck Greene McMurtry LLP
Following concerns that Pfizer Inc.'s proposed acquisition of Hospira Inc. will result in a substantial lessening of competition, Pfizer has reached an agreement with the Competition Bureau to sell the Canadian assets related to four pharmaceutical products distributed by the pharma giant in Canada.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners